A citation-based method for searching scientific literature

Linda Douw, Martin Klein, Selene Saa Fagel, Josje van den Heuvel, Martin Jb Taphoorn, Neil K Aaronson, Tjeerd J Postma, W Peter Vandertop, Jacob J Mooij, Rudolf H Boerman, Guus N Beute, Jasper D Sluimer, Ben J Slotman, Jaap C Reijneveld, Jan J Heimans. Lancet Neurol 2009
Times Cited: 389







List of co-cited articles
711 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.
M Klein, J J Heimans, N K Aaronson, H M van der Ploeg, J Grit, M Muller, T J Postma, J J Mooij, R H Boerman, G N Beute,[...]. Lancet 2002
361
33

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, Arnab Chakravarti, Mark R Gilbert, Geoffrey R Barger, Stephen Coons, Peter Ricci, Dennis Bullard, Paul D Brown,[...]. N Engl J Med 2016
447
29

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
28

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Brigitta G Baumert, Monika E Hegi, Martin J van den Bent, Andreas von Deimling, Thierry Gorlia, Khê Hoang-Xuan, Alba A Brandes, Guy Kantor, Martin J B Taphoorn, Mohamed Ben Hassel,[...]. Lancet Oncol 2016
215
23

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.
M J van den Bent, D Afra, O de Witte, M Ben Hassel, S Schraub, K Hoang-Xuan, P-O Malmström, L Collette, M Piérart, R Mirimanoff,[...]. Lancet 2005
556
19

Prognostic factors for survival in adult patients with cerebral low-grade glioma.
Francesco Pignatti, Martin van den Bent, Desmond Curran, Channa Debruyne, Richard Sylvester, Patrick Therasse, Denes Afra, Philippe Cornu, Michel Bolla, Charles Vecht,[...]. J Clin Oncol 2002
556
15


Cognitive deficits in adult patients with brain tumours.
Martin J B Taphoorn, Martin Klein. Lancet Neurol 2004
431
14

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.
A B Karim, B Maat, R Hatlevoll, J Menten, E H Rutten, D G Thomas, F Mascarenhas, J C Horiot, L M Parvinen, M van Reijn,[...]. Int J Radiat Oncol Biol Phys 1996
435
14

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J Brat, Roel G W Verhaak, Kenneth D Aldape, W K Alfred Yung, Sofie R Salama, Lee A D Cooper, Esther Rheinbay, C Ryan Miller, Mark Vitucci, Olena Morozova,[...]. N Engl J Med 2015
13

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
Paul D Brown, Kurt Jaeckle, Karla V Ballman, Elana Farace, Jane H Cerhan, S Keith Anderson, Xiomara W Carrero, Fred G Barker, Richard Deming, Stuart H Burri,[...]. JAMA 2016
661
11

Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
Vinai Gondi, Stephanie L Pugh, Wolfgang A Tome, Chip Caine, Ben Corn, Andrew Kanner, Howard Rowley, Vijayananda Kundapur, Albert DeNittis, Jeffrey N Greenspoon,[...]. J Clin Oncol 2014
546
11

Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.
Edward G Shaw, Meihua Wang, Stephen W Coons, David G Brachman, Jan C Buckner, Keith J Stelzer, Geoffrey R Barger, Paul D Brown, Mark R Gilbert, Minesh P Mehta. J Clin Oncol 2012
191
11

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.
N K Aaronson, S Ahmedzai, B Bergman, M Bullinger, A Cull, N J Duez, A Filiberti, H Flechtner, S B Fleishman, J C de Haes. J Natl Cancer Inst 1993
11

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Roger Stupp, Monika E Hegi, Warren P Mason, Martin J van den Bent, Martin J B Taphoorn, Robert C Janzer, Samuel K Ludwin, Anouk Allgeier, Barbara Fisher, Karl Belanger,[...]. Lancet Oncol 2009
10

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.
Martin J van den Bent, Alba A Brandes, Martin J B Taphoorn, Johan M Kros, Mathilde C M Kouwenhoven, Jean-Yves Delattre, Hans J J A Bernsen, Marc Frenay, Cees C Tijssen, Wolfgang Grisold,[...]. J Clin Oncol 2013
651
10

Radiation-induced brain injury: A review.
Dana Greene-Schloesser, Mike E Robbins, Ann M Peiffer, Edward G Shaw, Kenneth T Wheeler, Michael D Chan. Front Oncol 2012
311
10


Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life.
Martin Klein, Nadine H J Engelberts, Henk M van der Ploeg, Dorotheé G A Kasteleijn-Nolst Trenité, Neil K Aaronson, Martin J B Taphoorn, Hans Baaijen, W Peter Vandertop, Martin Muller, Tjeerd J Postma,[...]. Ann Neurol 2003
256
9

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
9

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.
Gregory Cairncross, Meihua Wang, Edward Shaw, Robert Jenkins, David Brachman, Jan Buckner, Karen Fink, Luis Souhami, Normand Laperriere, Walter Curran,[...]. J Clin Oncol 2013
608
9

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Eric L Chang, Jeffrey S Wefel, Kenneth R Hess, Pamela K Allen, Frederick F Lang, David G Kornguth, Rebecca B Arbuckle, J Michael Swint, Almon S Shiu, Moshe H Maor,[...]. Lancet Oncol 2009
9

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
Justin S Smith, Edward F Chang, Kathleen R Lamborn, Susan M Chang, Michael D Prados, Soonmee Cha, Tarik Tihan, Scott Vandenberg, Michael W McDermott, Mitchel S Berger. J Clin Oncol 2008
754
9

Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.
Roshan S Prabhu, Minhee Won, Edward G Shaw, Chen Hu, David G Brachman, Jan C Buckner, Keith J Stelzer, Geoffrey R Barger, Paul D Brown, Mark R Gilbert,[...]. J Clin Oncol 2014
61
14

Proton therapy for low-grade gliomas: Results from a prospective trial.
Helen A Shih, Janet C Sherman, Lisa B Nachtigall, Mary K Colvin, Barbara C Fullerton, Juliane Daartz, Barbara K Winrich, Tracy T Batchelor, Lauren T Thornton, Sarah M Mancuso,[...]. Cancer 2015
59
15

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
8

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
8

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Jaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, Jacoline E C Bromberg, Warren P Mason, Khê Hoang-Xuan, Gail Ryan, Mohamed Ben Hassel, Roelien H Enting, Alba A Brandes,[...]. Lancet Oncol 2016
54
14

Health-related quality of life in stable, long-term survivors of low-grade glioma.
Florien W Boele, Linda Douw, Jaap C Reijneveld, Rianne Robben, Martin J B Taphoorn, Neil K Aaronson, Jan J Heimans, Martin Klein. J Clin Oncol 2015
36
22

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
Michael Weller, Martin van den Bent, Jörg C Tonn, Roger Stupp, Matthias Preusser, Elizabeth Cohen-Jonathan-Moyal, Roger Henriksson, Emilie Le Rhun, Carmen Balana, Olivier Chinot,[...]. Lancet Oncol 2017
470
8

Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients.
O Surma-aho, M Niemelä, J Vilkki, M Kouri, A Brander, O Salonen, A Paetau, M Kallio, J Pyykkönen , J Jääskeläinen. Neurology 2001
229
8

The course of neurocognitive functioning in high-grade glioma patients.
Ingeborg Bosma, Maaike J Vos, Jan J Heimans, Martin J B Taphoorn, Neil K Aaronson, Tjeerd J Postma, Henk M van der Ploeg, Martin Muller, W Peter Vandertop, Ben J Slotman,[...]. Neuro Oncol 2007
106
7

Cognitive effects of tumour and surgical treatment in glioma patients.
Andrea Talacchi, Barbara Santini, Silvia Savazzi, Massimo Gerosa. J Neurooncol 2011
110
7

Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
Michael Wahl, Joanna J Phillips, Annette M Molinaro, Yi Lin, Arie Perry, Daphne A Haas-Kogan, Joseph F Costello, Manisha Dayal, Nicholas Butowski, Jennifer L Clarke,[...]. Neuro Oncol 2017
59
11

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
Paul D Brown, Stephanie Pugh, Nadia N Laack, Jeffrey S Wefel, Deepak Khuntia, Christina Meyers, Ali Choucair, Sherry Fox, John H Suh, David Roberge,[...]. Neuro Oncol 2013
432
7

Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.
Thomas B Daniels, Paul D Brown, Sara J Felten, Wenting Wu, Jan C Buckner, Robert M Arusell, Walter J Curran, Ross A Abrams, David Schiff, Edward G Shaw. Int J Radiat Oncol Biol Phys 2011
85
8

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Wolfgang Wick, Patrick Roth, Christian Hartmann, Peter Hau, Makoto Nakamura, Florian Stockhammer, Michael C Sabel, Antje Wick, Susanne Koeppen, Ralf Ketter,[...]. Neuro Oncol 2016
103
7

Neurocognitive effects of proton radiation therapy in adults with low-grade glioma.
Janet Cohen Sherman, Mary K Colvin, Sarah M Mancuso, Tracy T Batchelor, Kevin S Oh, Jay S Loeffler, Beow Y Yeap, Helen A Shih. J Neurooncol 2016
30
23

Compromised health-related quality of life in patients with low-grade glioma.
Neil K Aaronson, Martin J B Taphoorn, Jan J Heimans, Tjeerd J Postma, Chad M Gundy, Guus N Beute, Ben J Slotman, Martin Klein. J Clin Oncol 2011
98
7

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
Martin J B Taphoorn, Lily Claassens, Neil K Aaronson, Corneel Coens, Murielle Mauer, David Osoba, Roger Stupp, René O Mirimanoff, Martin J van den Bent, Andrew Bottomley. Eur J Cancer 2010
196
7

Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma.
Roshan Karunamuni, Hauke Bartsch, Nathan S White, Vitali Moiseenko, Ruben Carmona, Deborah C Marshall, Tyler M Seibert, Carrie R McDonald, Nikdokht Farid, Anithapriya Krishnan,[...]. Int J Radiat Oncol Biol Phys 2016
65
10

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
960
7

Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
Emma van Kessel, Anniek E Baumfalk, Martine J E van Zandvoort, Pierre A Robe, Tom J Snijders. J Neurooncol 2017
56
12

Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study.
Nadia N Laack, Paul D Brown, Robert J Ivnik, Alfred F Furth, Karla V Ballman, Julie E Hammack, Robert M Arusell, Edward G Shaw, Jan C Buckner. Int J Radiat Oncol Biol Phys 2005
97
7

Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma.
Kyle R Noll, Mariana E Bradshaw, Jeffrey S Weinberg, Jeffrey S Wefel. Psychooncology 2017
24
29

Cognitive deficits before treatment among patients with brain tumors.
O Tucha, C Smely, M Preier, K W Lange. Neurosurgery 2000
197
7

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Paul D Brown, Vinai Gondi, Stephanie Pugh, Wolfgang A Tome, Jeffrey S Wefel, Terri S Armstrong, Joseph A Bovi, Cliff Robinson, Andre Konski, Deepak Khuntia,[...]. J Clin Oncol 2020
151
7


Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.
Paul D Brown, Jan C Buckner, Judith R O'Fallon, Nancy L Iturria, Cerise A Brown, Brian P O'Neill, Bernd W Scheithauer, Robert P Dinapoli, Robert M Arusell, Walter J Curran,[...]. J Clin Oncol 2003
157
6



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.